Company Background
American Health Capital is pleased to introduce a compounding pharmacy for sale based in the New York City area that specializes in fertility services as well as weight loss, dermatology, and more. The company serves the local community with customized care for all their trusted patients. They own a magnificent state-of-the-art lab that follows and exceeds all safety standards.
Financial Summary
In 2022, the company had a gross revenue of $16,458,392 with an adjusted EBITDA of $183,645. In 2023, the company grew to a gross revenue of $19,923,037 with an adjusted EBITDA of $800,867. Growth is expected to continue into 2024, and the projected revenue is $21 million with a projected EBITDA of $1.15 million.
Areas of Growth
The growth over the trailing 12 months was due to expanding partnerships and implementing customized medicine to treat patients (compounding). The staff, who are all expected to stay on under new ownership, have a collective experience of 100+ years in the industry.
The current owners do not have the bandwidth to dedicate the proper time that is needed for this business to reach its full potential. There are many low hanging opportunities of growth that an experienced operator could implement and execute quickly.
Asking Price
The asking price for this opportunity is $9 million.
